InflaRx N.V. logo

InflaRx N.V.

NASDAQ:IFRX

Overview | Financials
Company Name InflaRx N.V.
Symbol IFRX
Currency USD
Price 2.47
Market Cap 145,441,751
Dividend Yield 0%
52-week-range 1.165 - 2.815
Industry Biotechnology
Sector Healthcare
CEO Dr. Niels C. Riedemann M.D., Ph.D.
Website https://www.inflarx.de

An error occurred while fetching data.

About InflaRx N.V.

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel

Related Stocks

Novo Integrated Sciences, Inc. logo

Novo Integrated Sciences, Inc.

NVOS

0.061 USD

DiaMedica Therapeutics Inc. logo

DiaMedica Therapeutics Inc.

DMAC

5.98 USD

Orgenesis Inc. logo

Orgenesis Inc.

ORGS

1.38 USD

Akebia Therapeutics, Inc. logo

Akebia Therapeutics, Inc.

AKBA

2.14 USD

Streamline Health Solutions, Inc. logo

Streamline Health Solutions, Inc.

STRM

4.164 USD

Rain Therapeutics Inc. logo

Rain Therapeutics Inc.

RAIN

3.65 USD

Bionomics Limited logo

Bionomics Limited

BNOX

0.253 USD

Financials

Numbers are in millions USD

Numbers are in millions USD